Efficacy and safety of consolidative camrelizumab following definitive concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell cancer
第一作者机构:[1]Radiotherapy Department, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China
推荐引用方式(GB/T 7714):
Wang J.,Cheng Y.,Wu Y.,et al.Efficacy and safety of consolidative camrelizumab following definitive concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell cancer[J].ANNALS OF ONCOLOGY.2022,33(7):S1124-S1124.
APA:
Wang, J.,Cheng, Y.,Wu, Y.,Cao, F.,Liu, Q.&Gao, G..(2022).Efficacy and safety of consolidative camrelizumab following definitive concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell cancer.ANNALS OF ONCOLOGY,33,(7)
MLA:
Wang, J.,et al."Efficacy and safety of consolidative camrelizumab following definitive concurrent chemoradiotherapy in patients with locally advanced esophageal squamous cell cancer".ANNALS OF ONCOLOGY 33..7(2022):S1124-S1124